col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


82 Ergebisse       Seite 1

 [1] 
Wiley: European Journal of Immunology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Apr―09 Diversification of the VH3-53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS-CoV-2 virus variants Matthias Bruhn, Maureen Obara, Abdus Salam, Bibiana Costa, Annett Ziegler, Inken Waltl, et al. (+6)
2 [GO] 2024―Apr―02 Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters Gerard Agbayani, Bassel Akache, Tyler M. Renner, Anh Tran, Matthew Stuible, Renu Dudani, et al. (+8)
3 [GO] 2024―Mrz―24 Age-related transcript changes in type I interferon signaling in children and adolescents with long COVID Matteo Fracella, Enrica Mancino, Raffaella Nenna, Chiara Virgillito, Federica Frasca, Alessandra D'Auria, et al. (+11)
4 [GO] 2023―Dez―13 Inactivated whole virion vaccine protects K18-hACE2 Tg mice against Omicron SARS-CoV-2 variant via cross-reactive T cells and non-neutralizing antibody responses. Andrey A. Kruglov, Marina A. Bondareva, Violetta S. Gogoleva, Iaroslav K. Semin, Irina V. Astrakhantseva, Ruslan Zvartsev, et al. (+9)
5 [GO] 2023―Okt―19 Aberrant neutrophil degranulation in hospitalized patients with COVID-19 partially remains for six months Florianne M.J. Hafkamp, Esther W. M. Taanman-Kueter, Toni M. M. van Capel, Elke Wynberg, Hugo D. G. van Willigen, Anouk Verveen, et al. (+8)
6 [GO] 2023―Okt―06 Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection Anis Barmada, Louis-François Handfield, Gerard Godoy-Tena, Carlos de la Calle-Fabregat, Laura Ciudad, Anna Arutyunyan, et al. (+32)
7 [GO] 2023―Sep―21 Nervous system-related tropism of SARS-CoV-2 and autoimmunity in COVID-19 infection Robert Weissert
8 [GO] 2023―Aug―23 SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice Charlie Fricke, Florian Pfaff, Lorenz Ulrich, Nico Joel Halwe, Jacob Schön, Laura Timm, et al. (+7)
9 [GO] 2023―Jul―13 B cell-intrinsic TLR7 signaling is required for neutralizing antibody responses to SARS-CoV-2 and pathogen-like COVID-19 vaccines Charles-Henry Miquel, Flora Abbas, Claire Cenac, Charlotte Foret-Lucas, Chang Guo, Mariette Ducatez, et al. (+3)
10 [GO] 2023―Jul―12 A design strategy to generate a SARS-CoV-2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses Christoph Ratswohl, Clara Vázquez García, Ata uW. Ahmad, Hannes Gonschior, Mikhail Lebedin, Casper Silvis, et al. (+7)
11 [GO] 2023―Jun―30 Serum TGFβ as a predictive biomarker for severe disease and fatality of COVID-19 Stefan Frischbutter, Pawel Durek, Mario Witkowski, Stefan Angermair, Sascha Treskatsch, Marcus Maurer, et al. (+2)
12 [GO] 2023―Mrz―01 Discriminating promiscuous from target-specific autoantibodies in COVID-19 Mikhail Lebedin, Clara Vázquez García, Lisa Spatt, Christoph Ratswohl, Charlotte Thibeault, Lennard Ostendorf, et al. (+5)
13 [GO] 2023―Jan―20 Antibody isotype epitope mapping of SARS-CoV-2 Spike RBD protein: targets for COVID-19 symptomatology and disease control Marinela Contreras, Joaquín Vicente, José Joaquín Cerón, Silvia Martinez Subiela, José Miguel Urra, Francisco J. Rodríguez-del-Río, et al. (+7)
14 [GO] 2022―Nov―21 Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID-19 and after yellow fever vaccination Elena Winheim, Tabea Eser, Flora Deák, Mohamed I. M. Ahmed, Olga Baranov, Linus Rinke, et al. (+15)
15 [GO] 2022―Okt―22 IL-13 determines specific IgE responses and SARS-CoV-2 immunity after mild COVID-19 and novel mRNA vaccination Stefan Meltendorf, Katrin Vogel, Christoph Thurm, Florian Prätsch, Annegret Reinhold, Jacqueline Färber, et al. (+8)
16 [GO] 2022―Okt―14 Neutrophil Activation and Neutrophil Extracellular Traps (Nets) in COVID-19 ARDS and Immunothrombosis Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, Elizabeth M. Gavioli, Giada Cremonesi, Akram Khan, et al. (+3)
17 [GO] 2022―Sep―15 Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice Patricia P. Ogger, Minerva Garcia Martín, Christina Michalaki, Jie Zhou, Jonathan C. Brown, Yue Du, et al. (+6)
18 [GO] 2022―Aug―17 Humanized mice for investigating SARS-CoV-2 lung infection and associated human immune responses Renren Sun, Zongzheng Zhao, Cong Fu, Yixin Wang, Zhendong Guo, Chunmao Zhang, et al. (+8)
19 [GO] 2022―Jul―14 Autoimmunity and SARS-CoV-2 infection: unraveling the link in neurological disorders Daniela Latorre
20 [GO] 2022―Jun―11 COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions Irene T. Schrijver, Charlotte Théroude, Nikolaos Antonakos, Jean Regina, Didier Le Roy, Pierre-Alexandre Bart, et al. (+5)
21 [GO] 2022―Mai―07 Differential susceptibility to SARS-CoV-2 in the normal nasal mucosa and in chronic sinusitis Zhili Zhang, Haoran Peng, Ju Lai, Liangliang Jiang, Liefu Wang, Shengkai Jin, et al. (+7)
22 [GO] 2022―Mai―02 Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID-19 inpatients David Haschka, Verena Petzer, Francesco Robert Burkert, Gernot Fritsche, Sophie Wildner, Rosa Bellmann-Weiler, et al. (+2)
23 [GO] 2022―Apr―14 Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity Federica Frasca, Mirko Scordio, Letizia Santinelli, Lucia Gabriele, Orietta Gandini, Anna Criniti, et al. (+7)
24 [GO] 2022―Apr―13 Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients Kerri Hagemann, Kristoffer Riecken, Johannes Jung, Heike Hildebrandt, Stephan Menzel, Madeleine Bunders, et al. (+9)
25 [GO] 2022―Apr―07 SARS-CoV-2 specific T-cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination Andrea Jarisch, Eliza Wiercinska, Shabnam Daqiq-Mirdad, Helen Hellstern, Salem Ajib, Anjali Cremer, et al. (+10)
26 [GO] 2022―Apr―06 COVID-19 vaccines - common misperceptions, false claims and myths explained Carsten Watzl
27 [GO] 2022―Mrz―21 Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects Anu Haveri, Anna Solastie, Nina Ekström, Pamela Österlund, Hanna Nohynek, Tuomo Nieminen, et al. (+2)
28 [GO] 2022―Mrz―21 Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity Manuel M. Vicente, Inês Alves, Joana Gaifem, Cláudia S. Rodrigues, Ângela Fernandes, Ana M. Dias, et al. (+12)
29 [GO] 2022―Mrz―07 Augmented Neutralization of SARS-CoV-2 Omicron Variant by Boost Vaccination and Monoclonal Antibodies Sebastian R. Schulz, Markus Hoffmann, Edith Roth, Katharina Pracht, Deborah L. Burnett, Ohan Mazigi, et al. (+7)
30 [GO] 2022―Mrz―05 Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccination Doris Urlaub, Natalie Wolfsdorff, Jan-Erik Hoffmann, Stefanie Dorok, Markus Hoffmann, Moritz Anft, et al. (+15)
31 [GO] 2022―Feb―07 The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19 Viktoria Hennings, Karolina Thörn, Sofie Albinsson, Christine Lingblom, Kerstin Andersson, Christer Andersson, et al. (+6)
32 [GO] 2022―Jan―31 SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs Lieve E.H. Donk, Julia Eder, John L. Hamme, Philip J.M. Brouwer, Mitch Brinkkemper, Ad C. Nuenen, et al. (+5)
33 [GO] 2021―Dez―15 COVID-19 Vaccine Inequity: High time to calibrate the global moral compass Mayda Gursel
34 [GO] 2021―Dez―06 Metabolic reprograming shapes neutrophil functions in severe COVID-19 Rebecca Borella, Sara De Biasi, Annamaria Paolini, Federica Boraldi, Domenico Lo Tartaro, Marco Mattioli, et al. (+14)
35 [GO] 2021―Dez―06 Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination Swantje I. Hammerschmidt, Christoph Thurm, Berislav Bošnjak, Günter Bernhardt, Annegret Reinhold, Stefanie Willenzon, et al. (+4)
36 [GO] 2021―Nov―27 COVID-19 specific metabolic imprint yields insights into multi organ-system perturbations Martin Cornillet, Benedikt Strunz, Olav Rooyackers, Andrea Ponzetta, Puran Chen, Jagadeeswara Rao Muvva, et al. (+28)
37 [GO] 2021―Nov―25 AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection Michele Spinicci, Alessio Mazzoni, Beatrice Borchi, Lucia Graziani, Marcello Mazzetti, Filippo Bartalesi, et al. (+10)
38 [GO] 2021―Okt―25 Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infection Luísa Canto e Castro, Andreia Gomes, Marta Serrano, Ana Helena Guia Pereira, Rita Ribeiro, Patrícia Napoleão, et al. (+13)
39 [GO] 2021―Okt―22 Altered increase in STAT1 expression and phosphorylation in severe COVID-19 Hector Rincon-Arevalo, Arman Aue, Jacob Ritter, Franziska Szelinski, Dmytro Khadzhynov, Daniel Zickler, et al. (+7)
40 [GO] 2021―Okt―04 Characterization of SARS-CoV-2 and common cold coronavirus-specific T cell responses in MIS-C and Kawasaki disease children Li-En Hsieh, Alba Grifoni, John Sidney, Chisato Shimizu, Hiroko Shike, Nanda Ramchandar, et al. (+4)
41 [GO] 2021―Sep―28 Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans Anu Haveri, Nina Ekström, Anna Solastie, Camilla Virta, Pamela Österlund, Elina Isosaari, et al. (+3)
42 [GO] 2021―Sep―26 SARS-CoV2 pneumonia recovery is linked to expansion of Innate Lymphoid Cells type 2 expressing CCR10 André MC Gomes, Guilherme B. Farias, Manuel Dias-Silva, Joel Laia, Amelia C. Trombetta, Ana Godinho-Santos, et al. (+9)
43 [GO] 2021―Sep―21 A surrogate cell-based SARS-CoV-2 spike blocking assay (SUBA) Wolfgang Schuh, Lena Baus, Tobit Steinmetz, Sebastian R. Schulz, Leonie Weckwerth, Edith Roth, et al. (+10)
44 [GO] 2021―Aug―23 SARS-CoV-2-reactive T cell receptors isolated from convalescent COVID-19 patients confer potent T cell effector function Fabian Brunk, Andreas Moritz, Annika Nelde, Tatjana Bilich, Nicolas Casadei, Sabine A. K. Fraschka, et al. (+8)
45 [GO] 2021―Aug―13 Specific detection of memory T-cells in COVID-19 patients using standardized whole-blood Interferon gamma release assay William Mouton, Christelle Compagnon, Kahina Saker, Soizic Daniel, Sophia Djebali, Xavier Lacoux, et al. (+13)
46 [GO] 2021―Aug―06 A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model Antonia Sophia Peter, Edith Roth, Sebastian R. Schulz, Kirsten Fraedrich, Tobit Steinmetz, Dominik Damm, et al. (+29)
47 [GO] 2021―Aug―06 Single-reaction multi-antigen serological test for comprehensive evaluation of SARS-CoV-2 patients by flow cytometry Yaiza Cáceres-Martell, Daniel Fernández-Soto, Carmen Campos-Silva, Eva M. García-Cuesta, Jose M Casasnovas, David Navas-Herrera, et al. (+10)
48 [GO] 2021―Aug―05 Successful treatment of COVID-19 infection with convalescent plasma in B cell-depleted patients may promote cellular immunity Andreas E. Kremer, Anita N. Kremer, Carsten Willam, Simon Völkl, Johan Verhagen, Susanne Achenbach, et al. (+15)
49 [GO] 2021―Aug―01 Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing Laura Marongiu, Giulia Protti, Fabio A. Facchini, Mihai Valache, Francesca Mingozzi, Valeria Ranzani, et al. (+16)
50 [GO] 2021―Jun―09 Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein Karol Palasiewicz, Sadiq Umar, Bianca Romay, Ryan K. Zomorrodi, Shiva Shahrara
51 [GO] 2021―Jun―05 Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice Huibin Lv, Owen Tak-Yin Tsang, Ray T. Y. So, Yiquan Wang, Meng Yuan, Hejun Liu, et al. (+10)
52 [GO] 2021―Mrz―31 Increased B Cell activity with consumption of activated monocytes in severe COVID-19 patients Igor Kos, Benedikt Balensiefer, Vadim Lesan, Dominic Kaddu-Mulindwa, Lorenz Thurner, Konstantin Christofyllakis, et al. (+15)
53 [GO] 2021―Mrz―31 Antigen-dependent multistep differentiation of T follicular helper cells and its role in SARS-CoV-2 infection and vaccination Dirk Baumjohann, Nicolas Fazilleau
54 [GO] 2021―Mrz―30 Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung-homing in patients with severe acute SARS-CoV-2 infection Silvia Spoerl, Anita N. Kremer, Michael Aigner, Nina Eisenhauer, Pauline Koch, Lina Meretuk, et al. (+15)
55 [GO] 2021―Mrz―27 Peptide microarray based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development Pavlo Holenya, Paul Joris Lange, Ulf Reimer, Wolfram Woltersdorf, Thomas Panterodt, Michael Glas, et al. (+10)
56 [GO] 2021―Mrz―27 A Single Subcutaneous or Intranasal Immunization with Adenovirus-Based SARS-CoV-2 Vaccine Induces Robust Humoral and Cellular Immune Responses in Mice Eun Kim, Florian J. Weisel, Stephen C. Balmert, Muhammad S. Khan, Shaohua Huang, Geza Erdos, et al. (+14)
57 [GO] 2021―Mrz―26 Enrichment of CCR6+CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19 Anno Saris, Tom D.Y. Reijnders, Martine Reijm, Jolien C. Hollander, Kim Buck, Alex R. Schuurman, et al. (+7)
58 [GO] 2021―Mrz―19 Complement cascade in severe forms of COVID-19: recent advances in therapy Nassima Chouaki Benmansour, Julien Carvelli, Eric Vivier
59 [GO] 2021―Mrz―09 Insights into coronavirus immunity taught by the murine coronavirus Sarah Grabherr, Burkhard Ludewig, Natalia Barbara Pikor
60 [GO] 2021―Mrz―06 Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection Farzan Solimani, Katharina Meier, Kamran Ghoreschi
61 [GO] 2021―Mrz―03 Organizing the 16th Spring School on Immunology during a pandemic Michael Lohoff, Melanie Wolf, Tanja Durez
62 [GO] 2021―Feb―14 High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2 Bernard Vanhove, Odile Duvaux, Juliette Rousse, Pierre-Joseph Royer, Gwénaëlle Evanno, Carine Ciron, et al. (+23)
63 [GO] 2021―Jan―15 Impact of COVID-19 pandemic on EJI and the extended immunological community
64 [GO] 2021―Jan―15 Academic labs supporting COVID-19 diagnostics Marc Veldhoen, Vanessa Zuzarte-Luis
65 [GO] 2020―Dez―25 Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19 O Blagova, N Varionchik, V Zaidenov, P Savina, N Sarkisova
66 [GO] 2020―Dez―13 Type-I Interferon assessment in 45 minutes using the FilmArray ® PCR platform in SARS-CoV-2 and other viral infections Marine Mommert, Magali Perret, Matthew Hockin, Sébastien Viel, Alexandre Belot, Jean-Christophe Richard, et al. (+7)
67 [GO] 2020―Dez―11 European female immunologists share their experiences during COVID-19 lock-downs
68 [GO] 2020―Dez―11 The impact of COVID-19 lock-downs for European (female) immunologists - our views as members of the EFIS gender and diversity task force Charlotte Esser, A. Mieke Boots, Anne Caignard, Ceren Ciraci, Danka Grčević, Sylvia Knapp, et al. (+5)
69 [GO] 2020―Dez―01 High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris François Anna, Sophie Goyard, Ana Ines Lalanne, Fabien Nevo, Marion Gransagne, Philippe Souque, et al. (+19)
70 [GO] 2020―Nov―30 Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients Ana Marcos-Jiménez, Santiago Sánchez-Alonso, Ana Alcaraz-Serna, Laura Esparcia, Celia López-Sanz, Miguel Sampedro-Núñez, et al. (+18)
71 [GO] 2020―Okt―21 Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to six months post disease onset Patrícia Figueiredo-Campos, Birte Blankenhaus, Catarina Mota, Andreia Gomes, Marta Serrano, Silvia Ariotti, et al. (+15)
72 [GO] 2020―Okt―20 Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients Alessio Mazzoni, Laura Maggi, Manuela Capone, Michele Spinicci, Lorenzo Salvati, Maria Grazia Colao, et al. (+14)
73 [GO] 2020―Okt―19 Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19 patients Anna E. Oja, Anno Saris, Cherien A. Ghandour, Natasja A.M. Kragten, Boris M. Hogema, Esther J. Nossent, et al. (+12)
74 [GO] 2020―Sep―04 Convalescent plasma treatment for COVID-19: tempering expectations with the influenza experience Kanta Subbarao, Francesca Mordant, Rajeev Rudraraju
75 [GO] 2020―Jul―24 Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia Sara De Biasi, Domenico Lo Tartaro, Marianna Meschiari, Lara Gibellini, Caterina Bellinazzi, Rebecca Borella, et al. (+15)
76 [GO] 2020―Jun―27 Immune response in children with COVID-19 is characterized by lower levels of T cell activation than infected adults Daniele Moratto, Mauro Giacomelli, Marco Chiarini, Lucia Savarè, Barbara Saccani, Mario Motta, et al. (+8)
77 [GO] 2020―Jun―25 LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins Liis Haljasmägi, Anu Remm, Anna Pauliina Rumm, Ekaterina Krassohhina, Hanna Sein, Anu Tamm, et al. (+2)
78 [GO] 2020―Mai―21 Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity Virgil Schijns, Ed C. Lavelle
79 [GO] 2020―Mai―21 COVID-19 vaccines: knowing the unknown Huibin Lv, Nicholas C. Wu, Chris K. P. Mok
80 [GO] 2020―Apr―27 An address to the European immunology community concerning the Coronavirus pandemic
81 [GO] 2020―Apr―27 Angry viruses make us sick: a child's depiction of SARS-CoV-2
82 [GO] 2020―Feb―27 COVID-19: Lessons from SARS and MERS Mirae Park, Ryan S. Thwaites, Peter J. M. Openshaw
 [1] 

82 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec